Zika virus infection medical therapy: Difference between revisions

Jump to navigation Jump to search
Sergekorjian (talk | contribs)
No edit summary
Nate Michalak (talk | contribs)
No edit summary
Line 16: Line 16:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Disease]]
[[Category:Infectious disease]]

Revision as of 21:45, 4 January 2016

Sexually transmitted diseases Main Page

Zika virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Zika Virus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Evaluation of Pregnant Women

Evaluation of Infants

Collection and Submission of Fetal Tissues

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission

Secondary Prevention

CDC Response Planning Tips

Risk-based Preparedness for States

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zika virus infection medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zika virus infection medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zika virus infection medical therapy

CDC on Zika virus infection medical therapy

Zika virus infection medical therapy in the news

Blogs on Zika virus infection medical therapy

Directions to Hospitals Treating Zika virus infection

Risk calculators and risk factors for Zika virus infection medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Nate Michalak, B.A.; Serge Korjian M.D.

Overview

The mainstay of therapy for Zika virus infection is supportive care. Supportive care includes includes rest, adequate fluids intake, and administration of antipyretics and analgesics. Aspirin and other NSAIDs should be avoided until Dengue fever is ruled out (NSAIDs may increase the risk of hemorrhage in Dengue fever). Antiviral treatment is not recommended for the management of Zika virus infection.

Medical Therapy

  • The mainstay of therapy for Zika virus infection is supportive care:
  • Rest
  • Adequate fluid intake
  • Pharmacologic therapy (i.e. antipyretic agents and/or analgesics). Aspirin and other NSAIDs should be avoided until Dengue fever is ruled out (NSAIDs may increase the risk of hemorrhage in Dengue fever).
  • Aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided until infection from other flaviviruses are no longer a potential diagnosis.[1]
  • Antiviral treatment is not recommended for the management of Zika virus infection.

References

  1. Zika virus. Center for Disease Control and Prevention for Medical Professionals. http://www.cdc.gov/zika/hc-providers/clinicalevaluation.html Accessed on December 14, 2015